Sanofi-Aventis Launches Bid for U.S. Pharma Firm

Jan. 11, 2010

Company made a $1.9 billion bid for Chattem

French pharmaceutical group Sanofi-Aventis on jan. 11 formally launched its takeover bid worth about $1.9 billion for U.S. non-prescription drug company Chattem.

The offer, announced in December and approved by the board of Chattem, is for all of the shares in the target company, one of the leaders in the U.S. market for non-prescription treatments.

The offer ends at midnight New York time on February 8, and is dependent on acceptance on behalf of a majority of ordinary shares and approval by regulators.

About the Author

Agence France-Presse

Copyright Agence France-Presse, 2002-2024. AFP text, photos, graphics and logos shall not be reproduced, published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP shall not be held liable for any delays, inaccuracies, errors or omissions in any AFP content, or for any actions taken in consequence.